First, grade II-III TAM-MGs showed female enrichment of pathways related to anti-tumor inflammatory activity (IFN alpha response, IFN gamma response, and IL6 JAK STAT3 signaling), as well as pathways involved in lipid metabolism (adipogenesis and cholesterol homeostasis) (Fig. 2D–F). The gene discussed is IFNG; the disease is neoplasm.